CNFE-SE: a novel approach combining complex network-based feature engineering and stacked ensemble to predict the success of intrauterine insemination and ranking the features.

Complex networks Feature engineering Feature selection IUI outcome prediction Stacked ensemble classifier

Journal

BMC medical informatics and decision making
ISSN: 1472-6947
Titre abrégé: BMC Med Inform Decis Mak
Pays: England
ID NLM: 101088682

Informations de publication

Date de publication:
02 01 2021
Historique:
received: 08 12 2019
accepted: 03 12 2020
entrez: 3 1 2021
pubmed: 4 1 2021
medline: 24 4 2021
Statut: epublish

Résumé

Intrauterine Insemination (IUI) outcome prediction is a challenging issue which the assisted reproductive technology (ART) practitioners are dealing with. Predicting the success or failure of IUI based on the couples' features can assist the physicians to make the appropriate decision for suggesting IUI to the couples or not and/or continuing the treatment or not for them. Many previous studies have been focused on predicting the in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) outcome using machine learning algorithms. But, to the best of our knowledge, a few studies have been focused on predicting the outcome of IUI. The main aim of this study is to propose an automatic classification and feature scoring method to predict intrauterine insemination (IUI) outcome and ranking the most significant features. For this purpose, a novel approach combining complex network-based feature engineering and stacked ensemble (CNFE-SE) is proposed. Three complex networks are extracted considering the patients' data similarities. The feature engineering step is performed on the complex networks. The original feature set and/or the features engineered are fed to the proposed stacked ensemble to classify and predict IUI outcome for couples per IUI treatment cycle. Our study is a retrospective study of a 5-year couples' data undergoing IUI. Data is collected from Reproductive Biomedicine Research Center, Royan Institute describing 11,255 IUI treatment cycles for 8,360 couples. Our dataset includes the couples' demographic characteristics, historical data about the patients' diseases, the clinical diagnosis, the treatment plans and the prescribed drugs during the cycles, semen quality, laboratory tests and the clinical pregnancy outcome. Experimental results show that the proposed method outperforms the compared methods with Area under receiver operating characteristics curve (AUC) of 0.84 ± 0.01, sensitivity of 0.79 ± 0.01, specificity of 0.91 ± 0.01, and accuracy of 0.85 ± 0.01 for the prediction of IUI outcome. The most important predictors for predicting IUI outcome are semen parameters (sperm motility and concentration) as well as female body mass index (BMI).

Sections du résumé

BACKGROUND
Intrauterine Insemination (IUI) outcome prediction is a challenging issue which the assisted reproductive technology (ART) practitioners are dealing with. Predicting the success or failure of IUI based on the couples' features can assist the physicians to make the appropriate decision for suggesting IUI to the couples or not and/or continuing the treatment or not for them. Many previous studies have been focused on predicting the in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) outcome using machine learning algorithms. But, to the best of our knowledge, a few studies have been focused on predicting the outcome of IUI. The main aim of this study is to propose an automatic classification and feature scoring method to predict intrauterine insemination (IUI) outcome and ranking the most significant features.
METHODS
For this purpose, a novel approach combining complex network-based feature engineering and stacked ensemble (CNFE-SE) is proposed. Three complex networks are extracted considering the patients' data similarities. The feature engineering step is performed on the complex networks. The original feature set and/or the features engineered are fed to the proposed stacked ensemble to classify and predict IUI outcome for couples per IUI treatment cycle. Our study is a retrospective study of a 5-year couples' data undergoing IUI. Data is collected from Reproductive Biomedicine Research Center, Royan Institute describing 11,255 IUI treatment cycles for 8,360 couples. Our dataset includes the couples' demographic characteristics, historical data about the patients' diseases, the clinical diagnosis, the treatment plans and the prescribed drugs during the cycles, semen quality, laboratory tests and the clinical pregnancy outcome.
RESULTS
Experimental results show that the proposed method outperforms the compared methods with Area under receiver operating characteristics curve (AUC) of 0.84 ± 0.01, sensitivity of 0.79 ± 0.01, specificity of 0.91 ± 0.01, and accuracy of 0.85 ± 0.01 for the prediction of IUI outcome.
CONCLUSIONS
The most important predictors for predicting IUI outcome are semen parameters (sperm motility and concentration) as well as female body mass index (BMI).

Identifiants

pubmed: 33388057
doi: 10.1186/s12911-020-01362-0
pii: 10.1186/s12911-020-01362-0
pmc: PMC7778826
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1

Références

Comput Methods Programs Biomed. 2018 Nov;166:77-89
pubmed: 30415720
Comput Biol Med. 2007 Feb;37(2):251-61
pubmed: 16616736
Fertil Steril. 2016 Jun;105(6):1462-8
pubmed: 26930619
Circulation. 2015 Nov 17;132(20):1920-30
pubmed: 26572668
Reprod Biomed Online. 2008 Aug;17(2):199-206
pubmed: 18681993
Fertil Steril. 2014 Jun;101(6):1649-55.e1-2
pubmed: 24690238
Hum Reprod. 1996 Apr;11(4):732-6
pubmed: 8671318
J Hum Reprod Sci. 2010 Sep;3(3):129-34
pubmed: 21234173
Fertil Steril. 1990 May;53(5):892-7
pubmed: 2185044
Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:159-62
pubmed: 24965998
Fertil Steril. 2004 Jul;82(1):45-51
pubmed: 15236988
Comput Methods Programs Biomed. 2020 Feb;184:105116
pubmed: 31629158
Fertil Steril. 2008 Feb;89(2):395-7
pubmed: 17482174
Reprod Biomed Online. 2003 Oct-Nov;7(4):485-92
pubmed: 14656412
Fertil Steril. 2006 Jun;85(6):1697-707
pubmed: 16682031
J Assist Reprod Genet. 2006 Feb;23(2):75-9
pubmed: 16496208
Fertil Steril. 2019 Feb;111(2):318-326
pubmed: 30611557
J Turk Ger Gynecol Assoc. 2018 Mar 19;19(2):57-64
pubmed: 29553043
Reprod Biomed Online. 2017 Jun;34(6):590-597
pubmed: 28396044
Clin Biochem. 2018 Dec;62:2-10
pubmed: 29555319
Biochem Med (Zagreb). 2014 Feb 15;24(1):12-8
pubmed: 24627710
Hum Reprod. 2006 Mar;21(3):738-44
pubmed: 16311292
IEEE Trans Neural Netw Learn Syst. 2018 Sep;29(9):4102-4115
pubmed: 29035230
Fertil Steril. 2013 Jan;99(1):63
pubmed: 23095139
Mater Sociomed. 2014 Oct;26(5):321-3
pubmed: 25568631
Hum Reprod Update. 2010 Sep-Oct;16(5):559; author reply 559
pubmed: 20542895
Fertil Steril. 2010 Jan;93(1):79-88
pubmed: 18996517
Hum Reprod. 1999 Mar;14(3):698-703
pubmed: 10221698
Fertil Steril. 2010 May 1;93(7):2316-20
pubmed: 19200970
Int J Fertil Steril. 2015 Oct-Dec;9(3):300-8
pubmed: 26644852
Fertil Steril. 1992 Jul;58(1):179-86
pubmed: 1624002
Int J Gynaecol Obstet. 2016 Apr;133(1):64-8
pubmed: 26873125
J Theor Biol. 2006 Oct 21;242(4):941-6
pubmed: 16806277
Hum Reprod. 2016 Jun;31(6):1141-6
pubmed: 27076499
Hum Reprod. 1995 Oct;10 Suppl 1:90-102
pubmed: 8592046
Fertil Steril. 1999 Apr;71(4):684-9
pubmed: 10202879
Hum Reprod. 2002 Dec;17(12):3122-8
pubmed: 12456611

Auteurs

Sima Ranjbari (S)

School of Industrial and Systems Engineering, Tarbiat Modares University, Tehran, Iran.

Toktam Khatibi (T)

School of Industrial and Systems Engineering, Tarbiat Modares University, Tehran, Iran. toktam.khatibi@modares.ac.ir.

Ahmad Vosough Dizaji (A)

Department of Genetics At Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Hesamoddin Sajadi (H)

Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Mehdi Totonchi (M)

Department of Reproductive Imaging, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. m.totonchi@royaninstitute.org.
Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. m.totonchi@royaninstitute.org.

Firouzeh Ghaffari (F)

Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH